The Pharmacy Times® Women's Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health conditions that affect women, including gynecological health and maternal health.
February 2nd 2023
CVS and Walgreens have both recently announced that they are seeking FDA certification to use the mail to distribute mifepristone, the first pill used in a 2-drug abortion.
Respiratory Syncytial Virus Vaccine Candidate Found to Protect Infants Against Severe Illness
November 2nd 2022Pre-planned safety reviews performed for the duration of the study found that the investigational vaccine is well-tolerated with no safety concerns for both the vaccinated individuals and their newborns.
Read More
Study: Dolutegravir-based Antiretroviral Therapies for HIV-1 Effective in Pregnancy
September 7th 2022Dolutegravir is a more recently approved ART that is a part of a once-a-day regimen found to be more effective, easier to tolerate, and less likely to create new drug resistance in people with HIV-1 compared with other antiretroviral drugs.
Read More